Inventor · disambiguated record
Peter Wilhelm Haebel
Also filed as: HAEBEL PETER WILHELM
7 granted patents·8 pending applications·106 citations·filing 2014–2025
85Inventor score
Top patents by PatentIndex Score
15 records- 0196US9713606B2Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin CBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jul 25, 2017·20 cites·25 claims
- 0296US8987249B2Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin CANDERSKEWITZ RALF·Filed 2014·Granted Mar 24, 2015·48 cites·26 claims
- 0395US10238633B2Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin CBOEHRINGER INGELHEIM INT·Filed 2017·Granted Mar 26, 2019·18 cites·25 claims
- 0491US9440960B2Substituted oxetanes and their use as inhibitors of cathepsin CBOEHRINGER INGELHEIM INT·Filed 2015·Granted Sep 13, 2016·17 cites·8 claims
- 0586US12054525B2NPY2 receptor agonistsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Aug 6, 2024·2 cites·12 claims
- 0686US2023310373A1Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin cBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0779US2020138780A1Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin cBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 0877US2021260027A1Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin cBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 0968US2019167636A1Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin cBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 1067US9340510B2Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereofBOEHRINGER INGELHEIM INT·Filed 2015·Granted May 17, 2016·1 cites·11 claims
- 1166US2015105375A1Methods for treating pulmonary emphysema using substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin cBOEHRINGER INGELHEIM INT·Filed 2014·Application pending·0 cites
- 1263US12391737B2Soluble NPY2 receptor agonistsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Aug 19, 2025·0 cites·18 claims
- 1363US2024247080A1Glp1/gip/npy2 receptor triple agonistsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1457US2021139548A1Npy2 receptor agonistsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1552US2025382344A1Soluble GLP1/GIP/NPY2 Receptor Triple AgonistsBOEHRINGER INGELHEIM INT GMH·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Wilhelm Haebel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →